JP2008524235A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008524235A5 JP2008524235A5 JP2007546882A JP2007546882A JP2008524235A5 JP 2008524235 A5 JP2008524235 A5 JP 2008524235A5 JP 2007546882 A JP2007546882 A JP 2007546882A JP 2007546882 A JP2007546882 A JP 2007546882A JP 2008524235 A5 JP2008524235 A5 JP 2008524235A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- implant
- polar aprotic
- optionally
- octreotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63627304P | 2004-12-15 | 2004-12-15 | |
| PCT/US2005/045346 WO2006065951A2 (en) | 2004-12-15 | 2005-12-15 | Sustained delivery formulations of octreotide compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008524235A JP2008524235A (ja) | 2008-07-10 |
| JP2008524235A5 true JP2008524235A5 (https=) | 2009-01-29 |
Family
ID=36588524
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007546882A Pending JP2008524235A (ja) | 2004-12-15 | 2005-12-15 | オクトレオチド化合物の徐放性送達処方物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20090092650A1 (https=) |
| EP (1) | EP1838285A2 (https=) |
| JP (1) | JP2008524235A (https=) |
| AU (1) | AU2005316545A1 (https=) |
| CA (1) | CA2590696A1 (https=) |
| WO (1) | WO2006065951A2 (https=) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8852638B2 (en) | 2005-09-30 | 2014-10-07 | Durect Corporation | Sustained release small molecule drug formulation |
| PL2079767T3 (pl) * | 2006-10-11 | 2015-05-29 | Tolmar Therapeutics Inc | Wytwarzanie biodegradowalnych poliestrów z właściwościami niskiego wyrzutu przez ekstrakcję płynem nadkrytycznym |
| ES2562878T3 (es) | 2007-05-25 | 2016-03-08 | Indivior Uk Limited | Formulaciones de liberación sostenida de compuestos de risperidona |
| WO2009148580A2 (en) * | 2008-06-03 | 2009-12-10 | Qlt Usa, Inc. | Controlled release copolymer formulation with improved release kinetics |
| US20100151033A1 (en) * | 2008-12-15 | 2010-06-17 | Novartis Ag | Octreotide depot formulation with constantly high exposure levels |
| US8815971B2 (en) | 2008-12-22 | 2014-08-26 | ATRP Solutions, Inc. | Control over controlled radical polymerization processes |
| US8822610B2 (en) * | 2008-12-22 | 2014-09-02 | ATRP Solutions, Inc. | Control over controlled radical polymerization processes |
| WO2010123574A1 (en) | 2009-04-23 | 2010-10-28 | Atrp Solutions Inc | Star macromolecules for personal and home care |
| US9783628B2 (en) | 2009-04-23 | 2017-10-10 | ATRP Solutions, Inc. | Dual-mechanism thickening agents for hydraulic fracturing fluids |
| US8173750B2 (en) | 2009-04-23 | 2012-05-08 | ATRP Solutions, Inc. | Star macromolecules for personal and home care |
| US9155745B2 (en) * | 2009-06-16 | 2015-10-13 | Universite De Geneve | Bevacizumab formulations with lower aggregation propensity, comprising corticosteroid anti-inflammatory drugs |
| BR112012002341A8 (pt) | 2009-08-06 | 2017-10-10 | Koninklijke Philips Electronics Nv | Semente radioativa para uso na terapia oncológica e método de terapia oncológica |
| WO2011087496A1 (en) * | 2010-01-13 | 2011-07-21 | Oakwood Laboratories LLC | Microspheres for the sustained release of octreotide without an initial time lag |
| CA2792771A1 (en) * | 2010-03-12 | 2011-09-15 | Surmodics, Inc. | Injectable drug delivery system |
| GB2513060B (en) | 2010-06-08 | 2015-01-07 | Rb Pharmaceuticals Ltd | Microparticle buprenorphine suspension |
| US9272044B2 (en) | 2010-06-08 | 2016-03-01 | Indivior Uk Limited | Injectable flowable composition buprenorphine |
| US9587064B2 (en) | 2010-12-08 | 2017-03-07 | ATRP Solutions, Inc. | Salt-tolerant star macromolecules |
| CN105189643B (zh) | 2012-08-30 | 2019-01-15 | 派诺聚合物技术公司 | 用于水力压裂液的双重机制增稠剂 |
| EP2951220B1 (en) | 2013-02-04 | 2020-11-25 | Pilot Polymer Technologies, Inc. | Salt-tolerant star macromolecules |
| EP2823808A1 (en) * | 2013-07-09 | 2015-01-14 | Ipsen Pharma S.A.S. | Pharmaceutical composition for a sustained release of lanreotide |
| GB201404139D0 (en) | 2014-03-10 | 2014-04-23 | Rb Pharmaceuticals Ltd | Sustained release buprenorphine solution formulations |
| CN107075015B (zh) | 2014-07-03 | 2019-08-23 | 派诺聚合物技术公司 | 表面活性剂-相容性星形大分子 |
| CA3015557C (en) | 2014-11-07 | 2019-07-16 | Indivior Uk Limited | The use of sustained-release buprenorphine formulations for the treatment of pain or opioid use disorders |
| JP6949820B2 (ja) * | 2015-08-03 | 2021-10-13 | トルマー インターナショナル リミテッド | 薬物の持続投与のための液体ポリマー送達システム |
| TW201720446A (zh) * | 2015-11-13 | 2017-06-16 | Ｏｈｒ製藥公司 | 非典型脈絡膜新生血管（ｃｎｖ）之大小做為以角鯊胺治療之預測子 |
| US10646484B2 (en) | 2017-06-16 | 2020-05-12 | Indivior Uk Limited | Methods to treat opioid use disorder |
| EP3803866A4 (en) | 2018-05-24 | 2022-03-16 | Nureva Inc. | METHOD, APPARATUS, AND COMPUTER READABLE MATERIALS FOR MANAGING SEMI-CONSTANT (PERSISTENT) SOUND SOURCES IN MICROPHONE CATCH/HOME AREAS |
| MX2020012459A (es) | 2018-05-24 | 2021-04-28 | Celanese Eva Performance Polymers Llc | Dispositivo implantable para liberacion sostenida de un compuesto de farmaco macromolecular. |
| KR20260007295A (ko) | 2018-05-24 | 2026-01-13 | 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 | 거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치 |
| JP2022506554A (ja) * | 2018-10-29 | 2022-01-17 | プージン ケミカル インダストリー カンパニー リミテッド | 耐高温性、耐老化性ポリグリコライドコポリマーおよびその組成 |
| CA3116438C (en) * | 2018-10-29 | 2023-08-22 | Pujing Chemical Industry Co., Ltd | Polyglycolide copolymer and preparation thereof |
| CN111214643A (zh) * | 2020-03-11 | 2020-06-02 | 苏州善湾生物医药科技有限公司 | 一种基于皮下凝胶缓释的奥曲肽组合物、制备方法及应用 |
| BR112023022439A2 (pt) | 2021-04-26 | 2023-12-26 | Celanese Eva Performance Polymers Llc | Dispositivo implantável para liberação sustentada de um composto de fármaco macromolecular |
| CN113318218A (zh) * | 2021-07-20 | 2021-08-31 | 国药一心制药有限公司 | 一种醋酸奥曲肽注射液及其制备工艺 |
| CN120131956A (zh) * | 2023-12-11 | 2025-06-13 | 中山大学中山眼科中心 | 生长激素抑制剂的用途、和含有生长激素抑制剂的药物组合物、制剂、及其装置 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6565874B1 (en) * | 1998-10-28 | 2003-05-20 | Atrix Laboratories | Polymeric delivery formulations of leuprolide with improved efficacy |
| WO2002049620A2 (en) * | 2000-12-21 | 2002-06-27 | Inhale Therapeutic Systems, Inc. | Induced phase transition method for the production of microparticles containing hydrophobic active agents |
| WO2002058671A1 (en) * | 2001-01-26 | 2002-08-01 | Debio Recherche Pharmaceutique S.A. | Burst free pharmaceutical microparticules |
| CA2502890A1 (en) * | 2002-11-05 | 2004-05-27 | Wellstat Biologics Corporation | Treating carcinoid neoplasms with therapeutic viruses |
| RU2355385C2 (ru) * | 2002-11-06 | 2009-05-20 | Алза Корпорейшн | Композиции пролонгированного действия с контролируемым высвобождением |
| US20040097419A1 (en) * | 2002-11-19 | 2004-05-20 | Holger Petersen | Organic compounds |
| US7803781B2 (en) * | 2003-02-28 | 2010-09-28 | Isis Pharmaceuticals, Inc. | Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| JP2007525429A (ja) * | 2003-03-11 | 2007-09-06 | キューエルティー ユーエスエー，インコーポレイテッド． | 細胞スケジュール依存性抗癌剤のための処方 |
| CN101193626A (zh) * | 2005-03-11 | 2008-06-04 | 益德威士医药股份有限公司 | 奥曲肽的受控释放制剂 |
-
2005
- 2005-12-15 JP JP2007546882A patent/JP2008524235A/ja active Pending
- 2005-12-15 WO PCT/US2005/045346 patent/WO2006065951A2/en not_active Ceased
- 2005-12-15 AU AU2005316545A patent/AU2005316545A1/en not_active Abandoned
- 2005-12-15 CA CA002590696A patent/CA2590696A1/en not_active Abandoned
- 2005-12-15 EP EP05849725A patent/EP1838285A2/en not_active Withdrawn
- 2005-12-15 US US11/793,296 patent/US20090092650A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008524235A5 (https=) | ||
| US20220354956A1 (en) | Biodegradable drug delivery for hydrophobic compositions | |
| CA2822854C (en) | Biodegradable drug delivery compositions | |
| ES2240236T3 (es) | Composicion de polimero biodegradable. | |
| JP6061823B2 (ja) | 改良された効力を備えた、ロイプロリドのポリマー送達処方物 | |
| JP4686653B2 (ja) | 低い初期薬物噴出性を有する制御放出性液状デリバリー組成物 | |
| JP2004510807A5 (https=) | ||
| US20090181068A1 (en) | Low Viscosity Liquid Polymeric Delivery System | |
| JPH05286850A (ja) | 放出を制御されたインプラントに使用する液状混合物、インプラントに好適なポリマーシステム及びそのポリマーシステムを用いた治療方法 | |
| CN101801415A (zh) | 利培酮化合物的持续递送制剂 | |
| JP2010531807A5 (https=) | ||
| RS56820B1 (sr) | Injektabilna tečna kompozicija koja sadrži buprenorfin | |
| JP2002537221A (ja) | 成形可能な固体のデリバリーシステム | |
| JPH05305135A (ja) | 生物分解性のある重合体組成物 | |
| CN102112107A (zh) | 具有改进的释放动力学特征的控制释放共聚物制剂 | |
| KR20200072322A (ko) | 온도감응형 하이드로겔을 이용한 서방성 약물전달체 제조방법 | |
| ES2370377T3 (es) | Sistema de administración de un líquido polimérico de baja viscosidad. | |
| Singh et al. | In Situ Forming Phase–inversion injectable Hydrogels for Controlled Drug Release | |
| HK1150982B (en) | Low viscosity liquid polymeric delivery system |